Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Andrade Robert sold 75,000 Fennec Pharmaceuticals Inc. shares (Form 4)
Traded Aug 27 to Aug 28, 2026 · Filed Aug 28, 2026
From Aug 27 to Aug 28, 2026, Andrade Robert (CHIEF FINANCIAL OFFICER) sold 75,000 Fennec Pharmaceuticals Inc. shares at US$11.78 for US$884K under a trading plan, leaving 239,603 shares. Filed Aug 28, 2026 (Form 4).
- Sold
- 75,000 shares
- Price
- US$11.78
- Value
- US$884K
- Holding after
- 239,603 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common shares | Sale | 75,000 | US$11.78 | 217,675 | Direct |
| Aug 28, 2026 | Common shares | Option exercise | 21,928 | US$5.10 | 239,603 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Andrade Robert
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Andrade Robert · Oct 1, 2026
- Form 4 · Andrade Robert · Aug 31, 2026
- Form 4 · Andrade Robert · Aug 3, 2026
- Form 4 · Andrade Robert · Jul 1, 2026
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026
- Form 4 · Hackman Jeffrey S. · Oct 13, 2026